In one of the most significant advancements in medtech, scientists have presented a smart capsule capable of monitoring and treating inflammation of the gut in real-time, which his manageable via smartphone app...
In a remarkable turn of events in the pharmaceutical trade globally, the API China 2025 has concluded its proceedings with a life-colored presence and thriving industry participation. The main event highlighted booming demand of active pharma...
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended donanemab for the treatment of early symptomatic Alzheimer's disease in adults with confirmed amyloid pathology who are heterozygotes
Apollo Hospitals and Siemens Healthineers have announced a strategic research alliance to foster innovation in liver disease diagnostics leveraging artificial intelligence (AI) and imaging, with a focus on developing AI-enabled clinical tools
In a major leap for India's biotech industry, accessible CAR-T therapy has not only reached patients sooner than expected but has also become commercially viable. ImmunoACT, the startup that created India's first indigenous CAR-T cell therapy...
As part of a trend that is causing concern in the industry regarding the quality of drugs and adherence to across-the-board manufacturing standards, major Indian drugmakers such as Sun Pharma, Lupin and Dr Reddy Laboratories have initiated volunt...
Patent specialists are sounding the alarm about the intellectual property terms in the recently finalized India-UK Trade Pact, which they claim will restrict India's ability to ensure affordable access to essential medicines...
Pfizer has entered a worldwide license deal, with the exception of China, with Chinese company 3SBio to obtain exclusive rights to develop, make, and sell 3SBio's investigational bispecific antibody, SSGJ-707.
Union Health Minister J P Nadda informed the Lok Sabha on Friday that an ICMR study had shown that the Covid vaccine did not raise the risk of sudden, unexplained deaths among young adults in India
A potential stem cell treatment for chronic liver failure was successfully evaluated by a startup based at the University of Hyderabad (UoH). The company claims that the treatment, known as Tulsi-28X, is the first in the world to employ a unique
, CDSCO.jpg)